Nasentropfen Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. By stimulating alpha‑1 receptors on nasal blood vessels, it causes vasoconstriction, which reduces mucosal edema and opens the nasal airway, providing rapid decongestion.

The appropriate dose and frequency are determined by a qualified healthcare professional based on the child’s age, weight, and severity of symptoms. Always follow the prescriber’s instructions and the product label.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should consult their physician before using the product to weigh potential risks and benefits.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Xylometazoline is an imidazoline‑type decongestant, offering rapid onset and short‑duration action. Compared with phenylephrine‑based sprays, it often provides longer relief with a lower risk of systemic side effects, but both classes share similar cautions regarding duration of use.

Store the product at room temperature, away from moisture and direct sunlight. Keep the bottle tightly closed in its original packaging to preserve stability and prevent contamination.

The drops are applied directly into each nostril using the supplied dropper. The prescriber will advise the exact number of drops per nostril and the interval between doses, typically not exceeding the recommended daily maximum.

Serious adverse events, although rare, include severe hypertension, allergic reactions such as rash or anaphylaxis, and rebound congestion if used for longer than the advised period. Immediate medical attention is required if these occur.

Children under 2 years of age, patients with known hypersensitivity to Xylometazoline or any formulation component, and individuals with uncontrolled hypertension or severe cardiovascular disease should avoid using this product.